07.27.15 VANITY FAIR
“Torture, American-Style: The Role of Money in Interrogations,”
A scathing new report reveals how the Defense Department and psychologists went in on what amounts to an “undisclosed joint venture.”
01.22.15 VANITY FAIR
“The Psychologists Who Taught the C.I.A. How to Torture (and Charged $180 Million)”
The C.I.A. tortured detainees in ways more brutal, sustained, and gruesome than was previously known, and two medical professionals were integral to its efforts.
05.21.14 READER’S DIGEST
“Drug Shortages: The Scary Reality of a World Without Meds”
Imagine surgeons running out of anesthetic drugs, cancer patients who can't get lifesaving chemotherapy, and doctors scrambling for the most basic antibiotics. We're already there.
03.28.14 FORTUNE MAGAZINE
“What ails Big Pharma”
A new book chronicles the uneasy relationship between money and drugs, and what it means for the rest of us.
02.12.14 FORTUNE MAGAZINE
“Ranbaxy’s empty promises”
On Jan. 23, the FDA dropped a heavy hammer on the Indian generic drug giant Ranbaxy Laboratories, announcing it will restrict imports from the company's manufacturing plant in Toansa, India.
10.23.13 FORTUNE MAGAZINE
“Painful prescription: Pharmacy benefit managers make out better than their customers”
In late 2008, Meridian Health Systems, a nonprofit that owns and operates six hospitals in southern New Jersey, hired a new pharmacy benefits management (PBM) company to help reduce the surging medication costs for its 12,000 employees and their families.
6.23.13 FORTUNE MAGAZINE
“Why the Supreme Court is wrong on generic drugs”
On Monday, in a 5-4 vote, the court ruled that since generic drugmakers are only replicating brand-name drugs that have already been deemed safe by the Food and Drug Administration, patients can’t sue to hold them liable for the dangerous design of a pharmaceutical.
“The latest to claim fraud at generic Lipitor maker Ranbaxy: Its owners”
Japanese drugmaker Daiichi Sankyo has quietly stood by its decision to purchase Ranbaxy in 2008. Now, though, the company is publicly suggesting it was defrauded in the $4.6 billion acquisition.
05.15.13 FORTUNE MAGAZINE
“Dirty medicine: The epic inside story of fraud at a generic Lipitor giant”
The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
01.23.13 FORTUNE MAGAZINE
“Maker of generic Lipitor pleads guilty to selling adulterated drugs”
Ranbaxy Laboratories pleads guilty to seven criminal counts.
“Are generics really the same as branded drugs?”
Consumers are told that generics are just like their name-brand counterparts. More medical professionals are starting to say that's not the case.
06.27.12 FORTUNE MAGAZINE
“The truth about the Fast and Furious scandal”
A Fortune investigation reveals that the ATF never intentionally allowed guns to fall into the hands of Mexican drug cartels. How the world came to believe just the opposite is a tale of rivalry, murder, and political bloodlust.
11/09/11 FORTUNE MAGAZINE
“OxyContin: Purdue Pharma’s painful medicine”
What the strange saga of Purdue and its $3 billion drug tells us about our national dependence on painkillers.
10/28/11 SELF MAGAZINE
“The Hidden Dangers of Outsourcing Radiology”
That scan of your brain, bones or breasts you got last Tuesday? It might have been read by someone who isn't a doctor and lives 12 time zones away. If, that is, anyone has bothered to read it at all.
05/09/11 FORTUNE MAGAZINE
“The War Over Lipitor”
You'd think that in this era of generic-drug dominance, making the transition to a non-branded version of Pfizer's vaunted cholesterol-fighting statin would be smooth, or at least controlled. And indeed, that's precisely how it — until just a few months ago.
04.04.11 FORTUNE MAGAZINE
Organized gangs are stealing prescription medicine in increasingly audacious heists. That's a problem for Big Pharma and for patients, who can unknowingly buy stolen — and sometimes dangerous — medications...
“What a Scientist Didn’t Tell the New York Times about His Study on Bee Deaths”
Few ecological disasters have been as confounding as the massive and devastating die-off of the world's honeybees. The phenomenon of Colony Collapse Disorder (CCD) — in which disoriented honeybees die far from their hives — has kept scientists, beekeepers, and regulators desperately seeking the cause.
03.31.10 NEW YORK TIMES
“Are You Buying Illegal Drugs?”
Last month, thieves cut through the roof of an Eli Lilly warehouse in Enfield, Conn, shimmied down a rope, disabled the alarms and made off with $75 million worth of psychiatric drugs, including the antidepressants Prozac and Cymbalta and the antipsychotic Zyprexa. It is thought to have been...
08/19/09 FORTUNE MAGAZINE
The “Medical Mafia”
LAS VEGAS (Fortune) It began as the most ordinary of fender-benders. Cynthia Johnson, an office manager for a real estate company, was driving to work on Interstate 15 near the Las Vegas strip when a fellow commuter clipped the rear bumper of her Toyota Avalon...
05/21/09 SELF MAGAZINE
Just when Beth Hubbard should have been feeling great, her health fell apart.
01/11/08 WORKING MOTHER
“Back to Life”
Depression is the last thing most moms expect to experience once their babies are sleeping through the night, talking up a storm and walking around. But one in five working women is depressed—and the illness can hit years after a child is born. We spoke with a few brave working moms about the crippling darkness that overtook their lives and their steps toward recovery.
03/01/08 CONDE NAST PORTFOLIO
“Your Hospital’s Deadly Secret”
The light of their lives was born 12 inches long. She weighed just one pound four ounces. Her skin fit like a baggy suit. But from the moment Baby Alyssa arrived 14 weeks early, she was the biggest thing in the Shinn family's world...
“The War on Terror: Rorschach and Awe”
Abu Zubaydah was a mess. It was early April 2002, and the al-Qaeda lieutenant had been shot in the groin during a firefight in Pakistan, then captured by the Special Forces and flown to a safe house in Thailand. Now he was experiencing life as America’s first high-value detainee in the wake of 9/11.